Literature DB >> 27504897

Association of Intestinal Microbiota with Metabolic Markers and Dietary Habits in Patients with Type 2 Diabetes.

Yoshiharu Yamaguchi1, Kazunori Adachi, Tomoya Sugiyama, Akihiro Shimozato, Masahide Ebi, Naotaka Ogasawara, Yasushi Funaki, Chiho Goto, Makoto Sasaki, Kunio Kasugai.   

Abstract

BACKGROUND/AIMS: Evidence suggests that intestinal microbiota, along with factors such as diet and host genetics, contributes to obesity, metabolic dysfunction and diabetes. Therefore, we examined the relationship between gut microbiota, blood metabolic markers, dietary habits and fecal short-chain fatty acids (SCFAs) in patients with type 2 diabetes mellitus (T2DM).
METHODS: Dietary habits, blood and fecal samples from 59 T2DM patients were recruited, and the association of intestinal microbiota with metabolic markers and dietary habits was analyzed.
RESULTS: Total energy intake was 1,692 ± 380 kcal/day. Carbohydrate, fat and protein intakes were 57.5 ± 5.2, 23.2 ± 5.3 and 13.2 ± 2.2%, respectively. Dietary habits - high carbohydrate, fat, and protein intake - were associated with increased counts of Clostridium clusters IV and XI and decreased counts of Bifidobacterium spp., order Lactobacillales and Clostridium cluster IV. Protein intake was negatively correlated with fecal acetate and total SCFAs. Total SCFAs, propionate and acetate were negatively correlated with blood insulin levels and the homeostasis model of insulin resistance.
CONCLUSION: Diets low in protein and carbohydrates favor a healthy gut microbiome and improve glucose tolerance in T2DM patients, although further elucidation of the role of the gut microbiome could lead to better therapies and prophylaxes.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27504897     DOI: 10.1159/000447690

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  25 in total

Review 1.  Close association between intestinal microbiota and irritable bowel syndrome.

Authors:  W-T Fan; C Ding; N-N Xu; S Zong; P Ma; B Gu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-07       Impact factor: 3.267

2.  Effects of dietary carbohydrate on 1,5-anhydroglucitol in a population without diabetes: results from the OmniCarb trial.

Authors:  S P Juraschek; E R Miller; L J Appel; R H Christenson; F M Sacks; E Selvin
Journal:  Diabet Med       Date:  2017-07-09       Impact factor: 4.359

3.  Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury.

Authors:  Kedan Cai; Yanhong Ma; Fanghao Cai; Xiaohan Huang; Liang Xiao; Chenyu Zhong; Pingping Ren; Qun Luo; Jianghua Chen; Fei Han
Journal:  Endocrine       Date:  2022-03-04       Impact factor: 3.633

4.  Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study.

Authors:  Akihiro Shimozato; Makoto Sasaki; Naotaka Ogasawara; Yasushi Funaki; Masahide Ebi; Chiho Goto; Satoshi Koikeda; Takashi Joh; Kunio Kasugai
Journal:  United European Gastroenterol J       Date:  2017-01-31       Impact factor: 4.623

Review 5.  Significance of Microbiota in Obesity and Metabolic Diseases and the Modulatory Potential by Medicinal Plant and Food Ingredients.

Authors:  Hoda M Eid; Michelle L Wright; N V Anil Kumar; Abdel Qawasmeh; Sherif T S Hassan; Andrei Mocan; Seyed M Nabavi; Luca Rastrelli; Atanas G Atanasov; Pierre S Haddad
Journal:  Front Pharmacol       Date:  2017-06-30       Impact factor: 5.810

6.  Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease.

Authors:  Elena Barengolts; Stefan J Green; Yuval Eisenberg; Arfana Akbar; Bharathi Reddivari; Brian T Layden; Lara Dugas; George Chlipala
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

7.  Intestinal microbiota mediates Enterotoxigenic Escherichia coli-induced diarrhea in piglets.

Authors:  Peng Bin; Zhiyi Tang; Shaojuan Liu; Shuai Chen; Yaoyao Xia; Jiaqi Liu; Hucong Wu; Guoqiang Zhu
Journal:  BMC Vet Res       Date:  2018-12-05       Impact factor: 2.741

8.  Intestinal Dysbiosis in Autoimmune Diabetes Is Correlated With Poor Glycemic Control and Increased Interleukin-6: A Pilot Study.

Authors:  Bruna Stevanato Higuchi; Nathália Rodrigues; Marina Ignácio Gonzaga; João Carlos Cicogna Paiolo; Nadine Stefanutto; Wellington Pine Omori; Daniel Guariz Pinheiro; João Luiz Brisotti; Euclides Matheucci; Vânia Sammartino Mariano; Gislane Lelis Vilela de Oliveira
Journal:  Front Immunol       Date:  2018-07-25       Impact factor: 7.561

9.  Xanthoceraside Could Ameliorate Alzheimer's Disease Symptoms of Rats by Affecting the Gut Microbiota Composition and Modulating the Endogenous Metabolite Levels.

Authors:  Hongxu Zhou; Jingjie Tai; Haiyan Xu; Xiumei Lu; Dali Meng
Journal:  Front Pharmacol       Date:  2019-09-13       Impact factor: 5.810

Review 10.  Causal Relationship between Diet-Induced Gut Microbiota Changes and Diabetes: A Novel Strategy to Transplant Faecalibacterium prausnitzii in Preventing Diabetes.

Authors:  Kumar Ganesan; Sookja Kim Chung; Jairam Vanamala; Baojun Xu
Journal:  Int J Mol Sci       Date:  2018-11-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.